We are live on ! Find out more
IRMD icon

iRadimed

79 hedge funds and large institutions have $152M invested in iRadimed in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.81% less ownership

Funds ownership: 44.84%44.04% (-0.81%)

8% less funds holding

Funds holding: 8679 (-7)

10% less capital invested

Capital invested by funds: $169M → $152M (-$16.9M)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
79
Holders Change
-7
Holders Change %
-8.14%
% of All Funds
1.27%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
35
Reduced
21
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CIA
26
Capital Impact Advisors
Massachusetts
$576K
Charles Schwab
27
Charles Schwab
California
$547K +$13.8K +484 +3%
LSV Asset Management
28
LSV Asset Management
Illinois
$518K +$524K +18,300 New
Two Sigma Advisers
29
Two Sigma Advisers
New York
$492K -$20K -700 -4%
Ameriprise
30
Ameriprise
Minnesota
$481K +$100K +3,499 +26%
SO
31
STRS Ohio
Ohio
$444K
Citadel Advisors
32
Citadel Advisors
Florida
$428K +$433K +15,145 New
CAM
33
ClariVest Asset Management
California
$391K -$5.72K -200 -1%
AllianceBernstein
34
AllianceBernstein
Tennessee
$376K +$17.2K +600 +5%
Los Angeles Capital Management
35
Los Angeles Capital Management
California
$361K +$89.3K +3,120 +32%
Calamos Advisors
36
Calamos Advisors
Illinois
$358K -$1.72M -60,105 -83%
CL
37
CIM LLC
New York
$318K -$1.14K -40 -0.4%
UBS Group
38
UBS Group
Switzerland
$281K +$261K +9,125 +1,154%
NA
39
Navellier & Associates
Nevada
$263K +$29.9K +1,045 +13%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$259K +$8.3K +290 +3%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$247K +$2.95K +103 +1%
CIS
42
Connors Investor Services
Pennsylvania
$232K
Man Group
43
Man Group
United Kingdom
$227K +$229K +8,012 New
MAM
44
Martingale Asset Management
Massachusetts
$225K +$143 +5 +0.1%
Barclays
45
Barclays
United Kingdom
$216K +$74K +2,587 +51%
Lazard Asset Management
46
Lazard Asset Management
New York
$161K +$343 +12 +0.2%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$149K -$286 -10 -0.2%
Bank of America
48
Bank of America
North Carolina
$141K +$84.2K +2,942 +143%
JP Morgan Chase
49
JP Morgan Chase
New York
$115K +$4.49K +157 +4%
MIM
50
MetLife Investment Management
New Jersey
$110K

IRMD Hedge Fund Activity: Q4 2022 in Review

79 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2022, worth a combined $152M — down 10% from $169M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of IRMD and 7 opened new positions — a net loss of 6 holders — while 21 trimmed existing stakes and 35 added.

The largest buyer was Soleus Capital Management, adding an estimated $1.73M. The largest seller was Resource Consulting Group, exiting entirely with an estimated $3.85M sold.

  • 79 institutional investors held iRadimed (IRMD) as of Q4 2022, down from 86 in Q3 2022.
  • Funds reported $152M of iRadimed stock for Q4 2022, down 10% quarter-over-quarter.
  • 7 funds opened new iRadimed positions in Q4 2022 and 13 closed out, a net change of -6 holders.
  • The largest iRadimed buyer in Q4 2022 was Soleus Capital Management, an estimated $1.73M added.
  • The largest iRadimed seller in Q4 2022 was Resource Consulting Group, an estimated $3.85M sold.

Based on aggregated 13F filings for Q4 2022.